<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2022.837762</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal and Neonatal Outcomes After Assisted Reproductive Technology: A Retrospective Cohort Study in China</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tai</surname> <given-names>Wen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Hu</surname> <given-names>Lingmin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Wen</surname> <given-names>Juan</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/774540/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Obstetrics, Nanjing Maternity and Child Health Care Hospital, Women&#x2019;s Hospital of Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Reproduction, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University</institution>, <addr-line>Changzhou</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Nanjing Maternity and Child Health Care Institute, Nanjing Maternity and Child Health Care Hospital, Women&#x2019;s Hospital of Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Anis Feki, Fribourg Cantonal Hospital, Switzerland</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Fangfang Chen, Capital Institute of Pediatrics, China; Rong Li, Peking University Third Hospital, China; Riadh Ben Temime, Charles Nicolle Hospital, Tunisia; Jing He, Guangzhou Medical University, China; Yichun Guan, The Third Affiliated Hospital of Zhengzhou University, China</p></fn>
<corresp id="c001">&#x002A;Correspondence: Lingmin Hu, <email>hulingmin1986@126.com</email></corresp>
<corresp id="c002">Juan Wen, <email>wenj2010@139.com</email></corresp>
<fn fn-type="other" id="fn004"><p>This article was submitted to Obstetrics and Gynecological Surgery, a section of the journal Frontiers in Medicine</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>05</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>837762</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>12</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>03</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Tai, Hu and Wen.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Tai, Hu and Wen</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>With the progress of assisted reproductive technology (ART) and the increasing number of ART pregnancy, its safety has become the focus of attention. The present study aimed to explore the associations of ART pregnancy with maternal and neonatal outcomes, as compared with naturally pregnancy.</p>
</sec>
<sec>
<title>Methods</title>
<p>This retrospective cohort study included all pregnant women who delivered at Women&#x2019;s Hospital of Nanjing Medical University in 2011&#x2013;2020. We compared maternal characteristics and pregnancy outcomes between group of ART pregnancy and group of naturally pregnancy using Logistic regression adjusted for confounders.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 13,604 ART pregnancies and 198,002 naturally pregnancies were included. The proportion of ART pregnancies has increased every year for the past 10 years, peaking in 2020 (9.0%). Multivariable logistic regression analysis showed that the risks of gestational diabetes, preeclampsia, moderate or severe anemia, liver-related diseases, thyroid-related diseases, preterm birth, placenta previa, postpartum hemorrhage, and cesarean section were significantly increased in ART pregnancy. For neonatal outcomes, women conceived by ART were more likely to have twins or multiples, and the risk of stillbirth or abnormal development was also significantly increased. When restriction to singletons, these risks were reduced. And the effects of ART on the risk of premature rupture of membrane, cord entanglement, intrapartum fever, cesarean section, and stillbirth or abnormal development were more pronounced in singletons pregnancies compared with that in pregnancies of twins or multiples.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Women conceived by ART were at increased risks of several adverse pregnancy outcomes compared with women conceived naturally. Multiple pregnancies could partly explain this phenomenon. For ART pregnancy, prenatal and intrapartum monitoring should be strengthened, and neonatal outcomes should be closely observed.</p>
</sec>
</abstract>
<kwd-group>
<kwd>maternal outcomes</kwd>
<kwd>neonatal outcomes</kwd>
<kwd>art</kwd>
<kwd>cohort</kwd>
<kwd>China</kwd>
</kwd-group>
<contract-sponsor id="cn001">Jiangsu Provincial Key Research and Development Program<named-content content-type="fundref-id">10.13039/501100013058</named-content></contract-sponsor>
<counts>
<fig-count count="1"/>
<table-count count="7"/>
<equation-count count="0"/>
<ref-count count="37"/>
<page-count count="9"/>
<word-count count="6364"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Since the birth of the first test-tube baby in 1978, assisted reproductive technology (ART) has become an effective treatment for infertility (<xref ref-type="bibr" rid="B1">1</xref>). With the progress of technology and provision of services, an increasing number of infants are born following ART therapy (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). In developed countries, ART pregnancies account for 1.5&#x2013;5.9% of all births (<xref ref-type="bibr" rid="B3">3</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>), while in China, ART pregnancies account for 1.7% and are increasing year by year (<xref ref-type="bibr" rid="B2">2</xref>). ART is sometimes defined differently and is usually defined as the application of laboratory or clinical techniques to gametes and/or embryos for reproductive purposes, however it has been broadened to include not only <italic>in vitro</italic> procedures but also ovarian stimulation with gonadotropins or ovariotropic drugs (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>). As these and other reproductive technologies expand, leading to a substantial number of successful pregnancies and births, it is critical for prospective parents to understand the maternal and neonatal outcomes associated with ART.</p>
<p>Several studies have shown that ART pregnancies have an increased risk of multiple pregnancy and adverse pregnancy outcomes, including gestational diabetes, gestational hypertension, placenta previa, preterm birth, operative delivery, low birth weight, birth defects and perinatal mortality (<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). However, other studies have concluded ART pregnancies do not have increased risks of adverse perinatal outcomes (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B19">19</xref>). The incidences of small for gestational age, preterm birth and cesarean section are similar between ART and naturally pregnancies (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Nevertheless, pregnancy outcomes in ART pregnancies appear to be generally poorer due to the increased risk of multiple pregnancies. Multiple pregnancy is a post-processing confounding factor, which appears after ART treatment and may confound causal effects. Many previous studies did not adjust for maternal age, BMI and other confounding factors (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B21">21</xref>&#x2013;<xref ref-type="bibr" rid="B23">23</xref>). It is not clear whether the increased risk of adverse pregnancy outcomes is due to ART itself, multiple births, or potential infertility. At present, opinions are too far apart to reach a consensus.</p>
<p>The present retrospective cohort study was conducted to compare maternal and neonatal outcomes between ART and naturally pregnancies, and in addition to explore the association of ART with adverse pregnancy outcomes by stratifying on birth plurality and maternal age.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Study Design and Population</title>
<p>This retrospective cohort study included all pregnant women who delivered at Women&#x2019;s Hospital of Nanjing Medical University in 2011&#x2013;2020. The Women&#x2019;s Hospital of Nanjing Medical University is the largest maternity hospital in Jiangsu province, China and delivers approximately 20,000 babies annually. After excluding women who had early abortions (&#x2264;12 weeks), or women who were discharged from care during pregnancy, a total of 211,606 pregnancies were included in the data analysis. Two cohorts were created: women who conceived by either intracytoplasmic sperm injection (ICSI), <italic>in vitro</italic> fertilization (IVF), ovulation induction (OI), gamete intra-fallopian transfer (GIFT), or artificial insemination (AI), were defined as group of ART pregnancy, and women who conceived naturally without ART, were considered as group of naturally pregnancy.</p>
</sec>
<sec id="S2.SS2">
<title>Data Collection</title>
<p>We obtained all maternal and neonatal information from Hospital Information System (HIS) Database. Data were collected from standardized clinical forms and hospital records after maternity discharge to form the research database. All data were extracted and cleaned by using Natural Language Processing (NLP) technique (<xref ref-type="bibr" rid="B24">24</xref>). Maternal characteristics of all pregnancies were firstly extracted, including maternal age (year), height (cm), intrapartum weight (kg), parity, birthplace (Jiangsu province in China, other provinces in China or other countries), menstrual cycle (21&#x2013;35 days, 36 days- or irregularity), abnormal pregnancy history and history of uterine fibroids. Maternal age was divided into five groups: &#x003C;25, 25&#x2013;29, 30&#x2013;34, 35&#x2013;39, &#x2265;40 years. Intrapartum body mass index (BMI, kg/m<sup>2</sup>) was calculated as maternal intrapartum weight divided by the square of height, and classified into four groups: &#x003C;25, 25&#x2013;29.9, 30&#x2013;34.9, &#x2265;35 kg/m<sup>2</sup>. Parity did not include this pregnancy and was divided into 0 (nulliparae) and &#x2265;1 (multiparae). Abnormal pregnancy history refers to a history of early abortion (&#x2265;2 times), intermediate and late abortion, abnormal development, or ectopic pregnancy.</p>
<p>We also used the HIS Database to obtain data on pregnancy complications, perinatal complications and neonatal outcomes. Data on pregnancy complications included gestational diabetes (fasting glucose concentrations &#x2265; 5.5 mmol/l or 2-h plasma glucose concentrations &#x2265; 8.0 mmol/l), preeclampsia (hypertension from 20 weeks&#x2019; gestation and proteinuria; severe preeclampsia was defined as preeclampsia with either a diastolic blood pressure &#x2265; 110 mmHg or proteinuria &#x2265; 5 g/day or both), anemia (hemoglobin &#x003C; 100 g/l and hematocrit &#x003C; 0.30; moderate or severe anemia was defined as hemoglobin &#x003C; 90 g/l or 60 g/l), liver-related diseases (cholestasis, hepatitis, liver function damage, etc.) and thyroid-related diseases (hyperthyroidism, hypothyroidism, thyroiditis, etc.). Data on perinatal complications included hospitalization time (day), preterm birth (&#x003C;37 weeks&#x2019; gestation), premature rupture of membrane, amniotic fluid pollution (clear as 0&#x00B0;, I&#x00B0;, II&#x00B0;, or III&#x00B0;), polyhydramnios (&#x003E;2,000 ml in the third trimester), oligohydramnios (&#x003C;300 ml in the third trimester), cord entanglement, torsion of cord, intrapartum fever (intrapartum temperature &#x003E; 38&#x00B0;C), placenta previa, antepartum hemorrhage, postpartum hemorrhage (measured blood loss &#x2265; 500 ml) and delivery mode (spontaneous labor or cesarean section). And data on neonatal outcomes included gestational weeks in birth, offspring gender, birth weight (g), macrosomia (birth weight &#x2265; 4,000 g), twins or multiples, fetal distress, stillbirth or abnormal development (fetal malformation).</p>
</sec>
<sec id="S2.SS3">
<title>Statistical Analyses</title>
<p>We compared maternal characteristics and pregnancy outcomes between group of ART pregnancy and group of naturally pregnancy. Continuous variables were described as mean and standard deviation (<inline-formula><mml:math id="INEQ10"><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo>&#x00AF;</mml:mo></mml:mover></mml:math></inline-formula> &#x00B1; <italic>s</italic>), and categorical variables were displayed as frequency (percentage). All comparisons between groups were conducted using standardized differences, which are not influenced by sample size and have been frequently used in previous large cohort studies (<xref ref-type="bibr" rid="B25">25</xref>&#x2013;<xref ref-type="bibr" rid="B27">27</xref>). A standardized difference &#x2265; 0.1 indicates meaningful difference between groups. The association between ART using and pregnancy outcomes were evaluated by logistic regression analysis. The crude and adjusted odds ratio (OR) with 95% confidence intervals (95%CI) for pregnancy outcomes were calculated. Adjusted values were adjusted for maternal age, intrapartum BMI, parity, birth plurality and abnormal pregnancy history. All statistical analyses were two-sided and performed using R software (version 3.2.2).</p>
</sec>
</sec>
<sec id="S3" sec-type="results">
<title>Results</title>
<p>A total of 211,606 women were included in this retrospective analysis, of whom 13,604 women conceived by ART as group of ART pregnancy, and 198,002 women conceived naturally without ART as group of naturally pregnancy. Over the past 10 years, the proportion of ART pregnancy has increased each year, reaching a peak in 2020 (9.0%) (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Of the ART pregnancy, the proportion of pregnant women over 35 years old and multiparae increased mildly, while the proportion of women with intrapartum BMI greater than 30 kg/m<sup>2</sup> decreased slightly. And with the implementation of the universal two-child policy in 2015, the proportion of women with abnormal pregnancy history in ART pregnancy decreased sharply, and then increased rapidly (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Yearly trends in percentage of assisted reproductive technology (ART) pregnancy and pregnancy with different characteristics from 2011 to 2020. <bold>(A)</bold> Percentage of ART pregnancy among all pregnancy; <bold>(B)</bold> Percentage of different characteristics among ART pregnancy.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-837762-g001.tif"/>
</fig>
<p>Maternal characteristics between ART and naturally pregnancy is summarized in <xref ref-type="table" rid="T1">Table 1</xref>. The mean maternal age and intrapartum BMI of women conceived by ART were significantly higher than those of women conceived naturally (standardized difference = 0.547 and 0.309, respectively). And women conceived by ART were more likely to be nulliparae (88.5% <italic>vs.</italic> 75.4%, standardized difference = 0.345), more likely to have a long or irregular menstrual cycle (15.2% <italic>vs.</italic> 7.9%, standardized difference = 0.230) and an abnormal pregnancy history (including early abortion, intermediate and late abortion, abnormal development, or ectopic pregnancy, 29.1% <italic>vs.</italic> 9.9%, standardized difference = 0.500), and more likely to have uterine fibroids (8.3% <italic>vs.</italic> 5.1%, standardized difference = 0.128). There were no significant standardized differences in maternal height and birthplace between the two groups.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Maternal characteristics between naturally pregnancy and assisted reproductive technology (ART) pregnancy.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Maternal characteristics</td>
<td valign="top" align="center">All pregnancy (<italic>n</italic> = 211606)</td>
<td valign="top" align="center">Naturally pregnancy (<italic>n</italic> = 198002)</td>
<td valign="top" align="center">ART pregnancy (<italic>n</italic> = 13604)</td>
<td valign="top" align="center">Standardized difference</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Maternal age [year, n (%)]</td>
<td valign="top" align="center">29.6 &#x00B1; 3.9</td>
<td valign="top" align="center">29.5 &#x00B1; 3.9</td>
<td valign="top" align="center">31.6 &#x00B1; 3.9</td>
<td valign="top" align="center">0.547</td>
</tr>
<tr>
<td valign="top" align="left">&#x003C;25</td>
<td valign="top" align="center">13274 (6.3)</td>
<td valign="top" align="center">13015 (6.6)</td>
<td valign="top" align="center">259 (1.9)</td>
<td valign="top" align="center">0.562</td>
</tr>
<tr>
<td valign="top" align="left">25-</td>
<td valign="top" align="center">104626 (49.4)</td>
<td valign="top" align="center">100616 (50.8)</td>
<td valign="top" align="center">4010 (29.5)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">30-</td>
<td valign="top" align="center">69047 (32.6)</td>
<td valign="top" align="center">62579 (31.6)</td>
<td valign="top" align="center">6468 (47.5)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">35-</td>
<td valign="top" align="center">21107 (10.0)</td>
<td valign="top" align="center">18711 (9.4)</td>
<td valign="top" align="center">2396 (17.6)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">40-</td>
<td valign="top" align="center">3550 (1.7)</td>
<td valign="top" align="center">3080 (1.6)</td>
<td valign="top" align="center">470 (3.5)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Height (cm)</td>
<td valign="top" align="center">162.0 &#x00B1; 4.7</td>
<td valign="top" align="center">162.1 &#x00B1; 4.7</td>
<td valign="top" align="center">161.8 &#x00B1; 4.7</td>
<td valign="top" align="center">0.066</td>
</tr>
<tr>
<td valign="top" align="left">Intrapartum weight (kg)</td>
<td valign="top" align="center">70.6 &#x00B1; 9.1</td>
<td valign="top" align="center">70.5 &#x00B1; 9.0</td>
<td valign="top" align="center">72.8 &#x00B1; 9.9</td>
<td valign="top" align="center">0.252</td>
</tr>
<tr>
<td valign="top" align="left">Intrapartum BMI [kg/m<sup>2</sup>, n (%)]</td>
<td valign="top" align="center">26.9 &#x00B1; 3.2</td>
<td valign="top" align="center">26.8 &#x00B1; 3.1</td>
<td valign="top" align="center">27.8 &#x00B1; 3.5</td>
<td valign="top" align="center">0.309</td>
</tr>
<tr>
<td valign="top" align="left">&#x003C;25</td>
<td valign="top" align="center">43730 (28.9)</td>
<td valign="top" align="center">41489 (29.5)</td>
<td valign="top" align="center">2241 (20.7)</td>
<td valign="top" align="center">0.287</td>
</tr>
<tr>
<td valign="top" align="left">25-</td>
<td valign="top" align="center">84527 (55.8)</td>
<td valign="top" align="center">78580 (55.9)</td>
<td valign="top" align="center">5947 (55)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">30-</td>
<td valign="top" align="center">20845 (13.8)</td>
<td valign="top" align="center">18569 (13.2)</td>
<td valign="top" align="center">2276 (21.1)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">35-</td>
<td valign="top" align="center">2323 (1.5)</td>
<td valign="top" align="center">1977 (1.4)</td>
<td valign="top" align="center">346 (3.2)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Parity [n (%)]</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.345</td>
</tr>
<tr>
<td valign="top" align="left">Nulliparae</td>
<td valign="top" align="center">161328 (76.2)</td>
<td valign="top" align="center">149292 (75.4)</td>
<td valign="top" align="center">12036 (88.5)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Multiparae</td>
<td valign="top" align="center">50278 (23.8)</td>
<td valign="top" align="center">48710 (24.6)</td>
<td valign="top" align="center">1568 (11.5)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Birthplace [n (%)]</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.039</td>
</tr>
<tr>
<td valign="top" align="left">Jiangsu province</td>
<td valign="top" align="center">196035 (93.9)</td>
<td valign="top" align="center">183445 (93.9)</td>
<td valign="top" align="center">12590 (93.0)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Other provinces</td>
<td valign="top" align="center">12773 (6.1)</td>
<td valign="top" align="center">11823 (6.1)</td>
<td valign="top" align="center">950 (7.0)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Menstrual cycle [day, n (%)]</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.230</td>
</tr>
<tr>
<td valign="top" align="left">21-</td>
<td valign="top" align="center">181015 (91.6)</td>
<td valign="top" align="center">169954 (92.1)</td>
<td valign="top" align="center">11061 (84.8)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">36- or Irregularity</td>
<td valign="top" align="center">16496 (8.4)</td>
<td valign="top" align="center">14521 (7.9)</td>
<td valign="top" align="center">1975 (15.2)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Abnormal pregnancy history [n (%)]</td>
<td valign="top" align="center">22559 (11.2)</td>
<td valign="top" align="center">18681 (9.9)</td>
<td valign="top" align="center">3878 (29.1)</td>
<td valign="top" align="center">0.500</td>
</tr>
<tr>
<td valign="top" align="left">Early abortion (&#x2265;2 times)</td>
<td valign="top" align="center">17181 (8.5)</td>
<td valign="top" align="center">14496 (7.7)</td>
<td valign="top" align="center">2685 (20.2)</td>
<td valign="top" align="center">0.366</td>
</tr>
<tr>
<td valign="top" align="left">Intermediate and late abortion or abnormal development</td>
<td valign="top" align="center">4205 (2.1)</td>
<td valign="top" align="center">3459 (1.8)</td>
<td valign="top" align="center">746 (5.6)</td>
<td valign="top" align="center">0.200</td>
</tr>
<tr>
<td valign="top" align="left">Ectopic pregnancy</td>
<td valign="top" align="center">3234 (1.6)</td>
<td valign="top" align="center">2114 (1.1)</td>
<td valign="top" align="center">1120 (8.4)</td>
<td valign="top" align="center">0.347</td>
</tr>
<tr>
<td valign="top" align="left">With uterine fibroids [n (%)]</td>
<td valign="top" align="center">11295 (5.3)</td>
<td valign="top" align="center">10160 (5.1)</td>
<td valign="top" align="center">1135 (8.3)</td>
<td valign="top" align="center">0.128</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>ART, assisted reproductive technology; BMI, body mass index.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<p>The incidences of pregnancy and perinatal complications in ART and naturally pregnancy was exhibited in <xref ref-type="table" rid="T2">Tables 2</xref>, <xref ref-type="table" rid="T3">3</xref>. Statistically significant increases were noted in gestational diabetes (28.0%), preeclampsia (5.4%), thyroid-related diseases (13.7%), preterm birth (20.4%), placenta previa (8.5%), postpartum hemorrhage (19.2%) and cesarean section (75.5%) in ART pregnancy, compared to naturally pregnancy (standardized difference &#x003E; 0.1). The occurring rates of anemia (25.9%), liver-related diseases (5.3%), polyhydramnios (3.4%), oligohydramnios (7.1%) and torsion of cord (3.3%) were also elevated in ART pregnancy, but with no significant difference (standardized difference &#x003C; 0.1). In contrast, there was a decline in the incidences of premature rupture of membrane (21.7%) and amniotic fluid pollution (I&#x00B0;: 4.2%, II&#x00B0;: 3.5%, III&#x00B0;: 3.6%) in ART pregnancy (standardized difference &#x003E; 0.1). We also analyzed neonatal outcomes between naturally pregnancy and ART pregnancy (<xref ref-type="table" rid="T4">Table 4</xref>). The mean birth weight of ART pregnancy was significantly lower than that of naturally pregnancy (standardized difference = 0.343). Moreover, significant rises of incidence were observed in twins or multiples (20.7%) and stillbirth or abnormal development (3.3%) in ART pregnancy (standardized difference &#x003E; 0.1). No significant difference was noted in macrosomia and fetal distress between the two groups.</p>
<table-wrap position="float" id="T2">
<label>TABLE 2</label>
<caption><p>The prevalence of pregnancy complications between naturally pregnancy and ART pregnancy.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Pregnancy complications [n (%)]</td>
<td valign="top" align="center">All pregnancy (<italic>n</italic> = 211606)</td>
<td valign="top" align="center">Naturally pregnancy (<italic>n</italic> = 198002)</td>
<td valign="top" align="center">ART pregnancy (<italic>n</italic> = 13604)</td>
<td valign="top" align="center">Standardized difference</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Gestational diabetes</td>
<td valign="top" align="center">39498 (18.7)</td>
<td valign="top" align="center">35687 (18.0)</td>
<td valign="top" align="center">3811 (28.0)</td>
<td valign="top" align="center">0.239</td>
</tr>
<tr>
<td valign="top" align="left">Preeclampsia</td>
<td valign="top" align="center">5122 (2.4)</td>
<td valign="top" align="center">4382 (2.2)</td>
<td valign="top" align="center">740 (5.4)</td>
<td valign="top" align="center">0.169</td>
</tr>
<tr>
<td valign="top" align="left">Severe preeclampsia</td>
<td valign="top" align="center">2279 (1.1)</td>
<td valign="top" align="center">1943 (1.0)</td>
<td valign="top" align="center">336 (2.5)</td>
<td valign="top" align="center">0.114</td>
</tr>
<tr>
<td valign="top" align="left">Anemia</td>
<td valign="top" align="center">47080 (22.2)</td>
<td valign="top" align="center">43552 (22.0)</td>
<td valign="top" align="center">3528 (25.9)</td>
<td valign="top" align="center">0.092</td>
</tr>
<tr>
<td valign="top" align="left">Moderate or severe anemia</td>
<td valign="top" align="center">7583 (3.6)</td>
<td valign="top" align="center">6892 (3.5)</td>
<td valign="top" align="center">691 (5.1)</td>
<td valign="top" align="center">0.079</td>
</tr>
<tr>
<td valign="top" align="left">Liver-related diseases</td>
<td valign="top" align="center">8321 (3.9)</td>
<td valign="top" align="center">7605 (3.8)</td>
<td valign="top" align="center">716 (5.3)</td>
<td valign="top" align="center">0.068</td>
</tr>
<tr>
<td valign="top" align="left">Thyroid-related diseases</td>
<td valign="top" align="center">19323 (9.1)</td>
<td valign="top" align="center">17463 (8.8)</td>
<td valign="top" align="center">1860 (13.7)</td>
<td valign="top" align="center">0.154</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>Liver-related diseases included intrahepatic cholestasis, hepatitis, liver dysfunction, liver damage etc., thyroid-related diseases included hyperthyroidism, hypothyroidism, thyroiditis, thyroid tumor, etc. ART, assisted reproductive technology.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T3">
<label>TABLE 3</label>
<caption><p>Perinatal complications between naturally pregnancy and ART pregnancy.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Perinatal complications</td>
<td valign="top" align="center">All pregnancy (<italic>n</italic> = 211606)</td>
<td valign="top" align="center">Naturally pregnancy (<italic>n</italic> = 198002)</td>
<td valign="top" align="center">ART pregnancy (<italic>n</italic> = 13604)</td>
<td valign="top" align="center">Standardized difference</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Hospitalization time (day)</td>
<td valign="top" align="center">5.6 &#x00B1; 2.3</td>
<td valign="top" align="center">5.6 &#x00B1; 2.3</td>
<td valign="top" align="center">6.2 &#x00B1; 2.6</td>
<td valign="top" align="center">0.274</td>
</tr>
<tr>
<td valign="top" align="left">Preterm birth<break/> [n (%)]</td>
<td valign="top" align="center">16054 (7.6)</td>
<td valign="top" align="center">13274 (6.7)</td>
<td valign="top" align="center">2780 (20.4)</td>
<td valign="top" align="center">0.409</td>
</tr>
<tr>
<td valign="top" align="left">Premature rupture of membrane<break/> [n (%)]</td>
<td valign="top" align="center">58537 (27.7)</td>
<td valign="top" align="center">55583 (28.1)</td>
<td valign="top" align="center">2954 (21.7)</td>
<td valign="top" align="center">0.147</td>
</tr>
<tr>
<td valign="top" align="left">Amniotic fluid pollution [n (%)]</td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center">0.178</td>
</tr>
<tr>
<td valign="top" align="left">Clear (0&#x00B0;)</td>
<td valign="top" align="center">134056 (83.0)</td>
<td valign="top" align="center">124330 (82.6)</td>
<td valign="top" align="center">9726 (88.6)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">I&#x00B0;</td>
<td valign="top" align="center">8630 (5.3)</td>
<td valign="top" align="center">8164 (5.4)</td>
<td valign="top" align="center">466 (4.2)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">II&#x00B0;</td>
<td valign="top" align="center">8872 (5.5)</td>
<td valign="top" align="center">8484 (5.6)</td>
<td valign="top" align="center">388 (3.5)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">III&#x00B0;</td>
<td valign="top" align="center">9944 (6.2)</td>
<td valign="top" align="center">9546 (6.3)</td>
<td valign="top" align="center">398 (3.6)</td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Polyhydramnios [n (%)]</td>
<td valign="top" align="center">5697 (2.7)</td>
<td valign="top" align="center">5236 (2.6)</td>
<td valign="top" align="center">461 (3.4)</td>
<td valign="top" align="center">0.044</td>
</tr>
<tr>
<td valign="top" align="left">Oligohydramnios [n (%)]</td>
<td valign="top" align="center">13656 (6.5)</td>
<td valign="top" align="center">12693 (6.4)</td>
<td valign="top" align="center">963 (7.1)</td>
<td valign="top" align="center">0.027</td>
</tr>
<tr>
<td valign="top" align="left">Cord entanglement [n (%)]</td>
<td valign="top" align="center">76217 (36.0)</td>
<td valign="top" align="center">71562 (36.1)</td>
<td valign="top" align="center">4655 (34.2)</td>
<td valign="top" align="center">0.040</td>
</tr>
<tr>
<td valign="top" align="left">Torsion of cord [n (%)]</td>
<td valign="top" align="center">6522 (3.1)</td>
<td valign="top" align="center">6073 (3.1)</td>
<td valign="top" align="center">449 (3.3)</td>
<td valign="top" align="center">0.013</td>
</tr>
<tr>
<td valign="top" align="left">Intrapartum fever [n (%)]</td>
<td valign="top" align="center">23815 (11.3)</td>
<td valign="top" align="center">22529 (11.4)</td>
<td valign="top" align="center">1286 (9.5)</td>
<td valign="top" align="center">0.063</td>
</tr>
<tr>
<td valign="top" align="left">Placenta previa [n (%)]</td>
<td valign="top" align="center">11483 (5.4)</td>
<td valign="top" align="center">10328 (5.2)</td>
<td valign="top" align="center">1155 (8.5)</td>
<td valign="top" align="center">0.130</td>
</tr>
<tr>
<td valign="top" align="left">Antepartum hemorrhage<break/> [n (%)]</td>
<td valign="top" align="center">557 (0.3)</td>
<td valign="top" align="center">513 (0.3)</td>
<td valign="top" align="center">44 (0.3)</td>
<td valign="top" align="center">0.012</td>
</tr>
<tr>
<td valign="top" align="left">Postpartum hemorrhage<break/> [n (%)]</td>
<td valign="top" align="center">22586 (10.7)</td>
<td valign="top" align="center">19979 (10.1)</td>
<td valign="top" align="center">2607 (19.2)</td>
<td valign="top" align="center">0.259</td>
</tr>
<tr>
<td valign="top" align="left">Cesarean section [n (%)]</td>
<td valign="top" align="center">89560 (42.7)</td>
<td valign="top" align="center">79317 (40.5)</td>
<td valign="top" align="center">10243 (75.5)</td>
<td valign="top" align="center">0.759</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>ART, assisted reproductive technology.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T4">
<label>TABLE 4</label>
<caption><p>Neonatal outcomes between naturally pregnancy and ART pregnancy.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Neonatal outcomes</td>
<td valign="top" align="center">All pregnancy (<italic>n</italic> = 211606)</td>
<td valign="top" align="center">Naturally pregnancy (<italic>n</italic> = 198002)</td>
<td valign="top" align="center">ART pregnancy (<italic>n</italic> = 13604)</td>
<td valign="top" align="center">Standardized difference</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Gestational weeks</td>
<td valign="top" align="center">38.7 &#x00B1; 1.9</td>
<td valign="top" align="center">38.8 &#x00B1; 1.8</td>
<td valign="top" align="center">37.7 &#x00B1; 2.4</td>
<td valign="top" align="center">0.519</td>
</tr>
<tr>
<td valign="top" align="left" colspan="4"><bold>Gender [n (%)]</bold></td>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Boy</td>
<td valign="top" align="center">90392 (52.2)</td>
<td valign="top" align="center">83808 (52.2)</td>
<td valign="top" align="center">6584 (51.9)</td>
<td valign="top" align="center">0.098</td>
</tr>
<tr>
<td valign="top" align="left">Girl</td>
<td valign="top" align="center">82813 (47.8)</td>
<td valign="top" align="center">76713 (47.8)</td>
<td valign="top" align="center">6100 (48.1)</td>
<td valign="top" align="center">0.102</td>
</tr>
<tr>
<td valign="top" align="left">Birth weight (g)</td>
<td valign="top" align="center">3321.2 &#x00B1; 507.9</td>
<td valign="top" align="center">3334.2 &#x00B1; 495.2</td>
<td valign="top" align="center">3139.6 &#x00B1; 632.2</td>
<td valign="top" align="center">0.343</td>
</tr>
<tr>
<td valign="top" align="left">Macrosomia<break/> [n (%)]</td>
<td valign="top" align="center">15301 (7.2)</td>
<td valign="top" align="center">14496 (7.3)</td>
<td valign="top" align="center">805 (5.9)</td>
<td valign="top" align="center">0.056</td>
</tr>
<tr>
<td valign="top" align="left">Twins or multiples [n (%)]</td>
<td valign="top" align="center">5201 (2.5)</td>
<td valign="top" align="center">2387 (1.2)</td>
<td valign="top" align="center">2814 (20.7)</td>
<td valign="top" align="center">0.657</td>
</tr>
<tr>
<td valign="top" align="left">Fetal distress<break/>[n (%)]</td>
<td valign="top" align="center">12956 (6.8)</td>
<td valign="top" align="center">12246 (6.9)</td>
<td valign="top" align="center">710 (5.5)</td>
<td valign="top" align="center">0.059</td>
</tr>
<tr>
<td valign="top" align="left">Stillbirth or abnormal development<break/> [n (%)]</td>
<td valign="top" align="center">2299 (1.1)</td>
<td valign="top" align="center">1845 (0.9)</td>
<td valign="top" align="center">454 (3.3)</td>
<td valign="top" align="center">0.167</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>ART, assisted reproductive technology.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<p>Multivariable logistic regression analysis showed that the association between ART and pregnancy outcomes were significant (<xref ref-type="table" rid="T5">Table 5</xref>). Nearly all the pregnancy complication listed, including gestational diabetes [aOR (95%CI) = 1.39 (1.33&#x2013;1.46)], preeclampsia [aOR (95%CI) = 1.26 (1.14&#x2013;1.41)], moderate or severe anemia [aOR (95%CI) = 1.20 (1.08&#x2013;1.32)], liver-related diseases [aOR (95%CI) = 1.14 (1.03&#x2013;1.26)], and thyroid-related diseases [aOR (95%CI) = 1.29 (1.21&#x2013;1.37)], were more likely to occur among women conceived by ART. In terms of perinatal complications, the risk of preterm birth [aOR (95%CI) = 1.61 (1.49&#x2013;1.74)], placenta previa [aOR (95%CI) = 1.48 (1.37&#x2013;1.60)], postpartum hemorrhage [aOR (95%CI) = 1.14 (1.08&#x2013;1.21)], and cesarean section [aOR (95%CI) = 2.84 (2.70&#x2013;2.99)] were significantly increased, while the risk of premature rupture of membrane [aOR (95%CI) = 0.66 (0.62&#x2013;0.71)], amniotic fluid pollution [I&#x00B0;: aOR (95%CI) = 0.83 (0.74&#x2013;0.92); II&#x00B0;: aOR (95%CI) = 0.66 (0.59&#x2013;0.74); III&#x00B0;: aOR (95%CI) = 0.57 (0.51&#x2013;0.64)], cord entanglement [aOR (95%CI) = 0.89 (0.85&#x2013;0.93)], and intrapartum fever [aOR (95%CI) = 0.69 (0.64&#x2013;0.74)] were significantly decreased in ART pregnancy as compared with naturally pregnancy. For neonatal outcomes, women conceived by ART were more likely to have twins or multiples [aOR (95%CI) = 24.20 (22.43&#x2013;26.11)], and the risk of stillbirth or abnormal development [aOR (95%CI) = 2.76 (2.39&#x2013;3.17)] was also significantly increased. Moreover, the risk of macrosomia [aOR (95%CI) = 0.88 (0.80&#x2013;0.95)] and fetal distress [aOR (95%CI) = 0.66 (0.60&#x2013;0.73)] were significantly decreased in ART pregnancy (<xref ref-type="table" rid="T5">Table 5</xref>).</p>
<table-wrap position="float" id="T5">
<label>TABLE 5</label>
<caption><p>The association of ART with maternal and offspring health.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center"/>
<td valign="top" align="center" colspan="2">Univariate<hr/></td>
<td valign="top" align="center" colspan="2">Multivariate<hr/></td>
</tr>
<tr>
<td valign="top" align="left">Maternal and offspring health</td>
<td valign="top" align="center">Naturally pregnancy</td>
<td valign="top" align="center">ART pregnancy</td>
<td valign="top" align="center"><italic>P</italic></td>
<td valign="top" align="center">ART pregnancy</td>
<td valign="top" align="center"><italic>P</italic></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left"><bold>Pregnancy complications</bold></td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Gestational diabetes (<italic>n</italic> = 39498)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.77 (1.70&#x2013;1.84)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.39 (1.33&#x2013;1.46)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Preeclampsia (<italic>n</italic> = 5122)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">2.54 (2.35&#x2013;2.75)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.26 (1.14&#x2013;1.41)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Severe preeclampsia (<italic>n</italic> = 2279)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">2.56 (2.27&#x2013;2.87)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.12 (0.96&#x2013;1.31)</td>
<td valign="top" align="center">0.146</td>
</tr>
<tr>
<td valign="top" align="left">Anemia (<italic>n</italic> = 47080)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.24 (1.19&#x2013;1.29)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.01 (0.96&#x2013;1.06)</td>
<td valign="top" align="center">0.678</td>
</tr>
<tr>
<td valign="top" align="left">Moderate or severe anemia (<italic>n</italic> = 7583)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.48 (1.37&#x2013;1.61)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.20 (1.08&#x2013;1.32)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Liver-related diseases (<italic>n</italic> = 8321)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.39 (1.29&#x2013;1.50)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.14 (1.03&#x2013;1.26)</td>
<td valign="top" align="center">0.012</td>
</tr>
<tr>
<td valign="top" align="left">Thyroid-related diseases (<italic>n</italic> = 19323)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.64 (1.56&#x2013;1.72)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.29 (1.21&#x2013;1.37)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Perinatal complications</bold></td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Preterm birth (<italic>n</italic> = 16054)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">3.58 (3.42&#x2013;3.74)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.61 (1.49&#x2013;1.74)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Premature rupture of membrane (<italic>n</italic> = 58537)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.71 (0.68&#x2013;0.74)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.66 (0.62&#x2013;0.71)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Amniotic fluid pollution</bold></td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">I&#x00B0; (<italic>n</italic> = 8630)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.73 (0.66&#x2013;0.80)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.83 (0.74&#x2013;0.92)</td>
<td valign="top" align="center">0.001</td>
</tr>
<tr>
<td valign="top" align="left">II&#x00B0; (<italic>n</italic> = 8872)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.58 (0.53&#x2013;0.65)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.66 (0.59&#x2013;0.74)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">III&#x00B0; (<italic>n</italic> = 9944)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.53 (0.48&#x2013;0.59)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.57 (0.51&#x2013;0.64)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Polyhydramnios (<italic>n</italic> = 5697)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.29 (1.17&#x2013;1.42)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.00 (0.89&#x2013;1.13)</td>
<td valign="top" align="center">0.992</td>
</tr>
<tr>
<td valign="top" align="left">Oligohydramnios (<italic>n</italic> = 13656)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.11 (1.04&#x2013;1.19)</td>
<td valign="top" align="center">0.002</td>
<td valign="top" align="center">1.00 (0.92&#x2013;1.08)</td>
<td valign="top" align="center">0.968</td>
</tr>
<tr>
<td valign="top" align="left">Cord entanglement (<italic>n</italic> = 76217)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.92 (0.89&#x2013;0.95)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.89 (0.85&#x2013;0.93)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Torsion of cord (<italic>n</italic> = 6522)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.08 (0.98&#x2013;1.19)</td>
<td valign="top" align="center">0.128</td>
<td valign="top" align="center">0.93 (0.83&#x2013;1.05)</td>
<td valign="top" align="center">0.235</td>
</tr>
<tr>
<td valign="top" align="left">Intrapartum fever (<italic>n</italic> = 23815)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.81 (0.77&#x2013;0.86)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.69 (0.64&#x2013;0.74)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Placenta previa (<italic>n</italic> = 11483)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.69 (1.58&#x2013;1.80)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.48 (1.37&#x2013;1.60)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Antepartum hemorrhage (<italic>n</italic> = 557)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.25 (0.92&#x2013;1.70)</td>
<td valign="top" align="center">0.157</td>
<td valign="top" align="center">0.82 (0.50&#x2013;1.34)</td>
<td valign="top" align="center">0.421</td>
</tr>
<tr>
<td valign="top" align="left">Postpartum hemorrhage (<italic>n</italic> = 22586)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">2.11 (2.02&#x2013;2.21)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">1.14 (1.08&#x2013;1.21)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Cesarean section (<italic>n</italic> = 79317)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">4.53 (4.35&#x2013;4.72)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">2.84 (2.70&#x2013;2.99)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left"><bold>Neonatal outcomes</bold></td>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
<td valign="top" align="center"/>
</tr>
<tr>
<td valign="top" align="left">Macrosomia (<italic>n</italic> = 15301)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.80 (0.74&#x2013;0.86)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.88 (0.80&#x2013;0.95)</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Twins or multiples (<italic>n</italic> = 5201)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">21.37 (20.17&#x2013;22.65)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">24.20 (22.43&#x2013;26.11)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Fetal distress (<italic>n</italic> = 12956)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.78 (0.72&#x2013;0.84)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">0.66 (0.60&#x2013;0.73)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Stillbirth or abnormal development (<italic>n</italic> = 2299)</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">3.67 (3.31&#x2013;4.07)</td>
<td valign="top" align="center">&#x003C;0.001</td>
<td valign="top" align="center">2.76 (2.39&#x2013;3.17)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>All values are ORs (95% CIs). Values were determined by using logistic regression. Adjusted values were adjusted for maternal age, intrapartum BMI, parity, birth plurality and abnormal pregnancy history. For odds of twins or multiples, adjusted values were adjusted for maternal age, intrapartum BMI, parity and abnormal pregnancy history.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<p>The association of ART with maternal and neonatal outcomes were also evaluated by stratifying on birth plurality and maternal age (<xref ref-type="table" rid="T6">Tables 6</xref>, <xref ref-type="table" rid="T7">7</xref>). When restriction to singletons, the risks of adverse pregnancy outcomes as listed above were reduced. And the effects of ART on the risk of premature rupture of membrane, cord entanglement, intrapartum fever, cesarean section, and stillbirth or abnormal development (ART pregnancy vs. naturally pregnancy) were more pronounced among singleton pregnancies compared with that among pregnancies of twins or multiples, while the effect of ART on the risk of polyhydramnios was more prominent among pregnancies of twins or multiples (heterogeneity test: <italic>P</italic> &#x003C; 0.05). When stratified by maternal age, we found the effects of ART on the risk of preterm birth, placenta previa, postpartum hemorrhage and cesarean section (ART pregnancy vs. naturally pregnancy) were more pronounced among women under 35 years compared with that among women over 30 years, while the effect of ART on the risk of polyhydramnios was more prominent among women over 35 years (heterogeneity test: <italic>P</italic> &#x003C; 0.05).</p>
<table-wrap position="float" id="T6">
<label>TABLE 6</label>
<caption><p>Stratified analysis on the association of ART with maternal and offspring health by birth plurality.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="left"/>
<td valign="top" align="center" colspan="3">ART pregnancy<hr/></td>
</tr>
<tr>
<td valign="top" align="left">Maternal and offspring health</td>
<td valign="top" align="center">Naturally pregnancy</td>
<td valign="top" align="center">Singletons</td>
<td valign="top" align="center">Twins or multiples</td>
<td valign="top" align="center"><italic>P</italic></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5"><bold>Pregnancy complications</bold></td>
</tr>
<tr>
<td valign="top" align="left">Gestational diabetes</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.40 (1.33&#x2013;1.47)</td>
<td valign="top" align="center">1.34 (1.12&#x2013;1.61)</td>
<td valign="top" align="center">0.648</td>
</tr>
<tr>
<td valign="top" align="left">Preeclampsia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.27 (1.12&#x2013;1.43)</td>
<td valign="top" align="center">1.24 (0.99&#x2013;1.56)</td>
<td valign="top" align="center">0.856</td>
</tr>
<tr>
<td valign="top" align="left">Severe preeclampsia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.11 (0.92&#x2013;1.34)</td>
<td valign="top" align="center">1.10 (0.81&#x2013;1.48)</td>
<td valign="top" align="center">0.960</td>
</tr>
<tr>
<td valign="top" align="left">Anemia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.00 (0.94&#x2013;1.05)</td>
<td valign="top" align="center">1.15 (0.99&#x2013;1.33)</td>
<td valign="top" align="center">0.082</td>
</tr>
<tr>
<td valign="top" align="left">Moderate or severe anemia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.17 (1.05&#x2013;1.31)</td>
<td valign="top" align="center">1.35 (1.02&#x2013;1.79)</td>
<td valign="top" align="center">0.353</td>
</tr>
<tr>
<td valign="top" align="left">Liver-related diseases</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.17 (1.04&#x2013;1.30)</td>
<td valign="top" align="center">1.06 (0.82&#x2013;1.37)</td>
<td valign="top" align="center">0.489</td>
</tr>
<tr>
<td valign="top" align="left">Thyroid-related diseases</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.30 (1.22&#x2013;1.39)</td>
<td valign="top" align="center">1.21 (0.98&#x2013;1.50)</td>
<td valign="top" align="center">0.528</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5"><bold>Perinatal complications</bold></td>
</tr>
<tr>
<td valign="top" align="left">Preterm birth</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.64 (1.49&#x2013;1.80)</td>
<td valign="top" align="center">1.44 (1.24&#x2013;1.66)</td>
<td valign="top" align="center">0.142</td>
</tr>
<tr>
<td valign="top" align="left">Premature rupture of membrane</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.65 (0.61&#x2013;0.70)</td>
<td valign="top" align="center">0.91 (0.71&#x2013;1.16)</td>
<td valign="top" align="center">0.010</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5"><bold>Amniotic fluid pollution</bold></td>
</tr>
<tr>
<td valign="top" align="left">I&#x00B0;</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.83 (0.74&#x2013;0.93)</td>
<td valign="top" align="center">0.81 (0.45&#x2013;1.47)</td>
<td valign="top" align="center">0.937</td>
</tr>
<tr>
<td valign="top" align="left">II&#x00B0;</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.67 (0.60&#x2013;0.76)</td>
<td valign="top" align="center">0.40 (0.18&#x2013;0.90)</td>
<td valign="top" align="center">0.214</td>
</tr>
<tr>
<td valign="top" align="left">III&#x00B0;</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.58 (0.52&#x2013;0.65)</td>
<td valign="top" align="center">0.29 (0.13&#x2013;0.67)</td>
<td valign="top" align="center">0.101</td>
</tr>
<tr>
<td valign="top" align="left">Polyhydramnios</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.09 (0.96&#x2013;1.24)</td>
<td valign="top" align="center">0.72 (0.53&#x2013;0.97)</td>
<td valign="top" align="center">0.013</td>
</tr>
<tr>
<td valign="top" align="left">Oligohydramnios</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.02 (0.94&#x2013;1.10)</td>
<td valign="top" align="center">0.96 (0.68&#x2013;1.36)</td>
<td valign="top" align="center">0.738</td>
</tr>
<tr>
<td valign="top" align="left">Cord entanglement</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.88 (0.84&#x2013;0.92)</td>
<td valign="top" align="center">1.08 (0.93&#x2013;1.26)</td>
<td valign="top" align="center">0.011</td>
</tr>
<tr>
<td valign="top" align="left">Torsion of cord</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.96 (0.85&#x2013;1.09)</td>
<td valign="top" align="center">0.68 (0.45&#x2013;1.03)</td>
<td valign="top" align="center">0.118</td>
</tr>
<tr>
<td valign="top" align="left">Intrapartum fever</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.68 (0.63&#x2013;0.73)</td>
<td valign="top" align="center">1.09 (0.82&#x2013;1.47)</td>
<td valign="top" align="center">0.002</td>
</tr>
<tr>
<td valign="top" align="left">Placenta previa</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.46 (1.35&#x2013;1.58)</td>
<td valign="top" align="center">1.96 (1.28&#x2013;3.00)</td>
<td valign="top" align="center">0.183</td>
</tr>
<tr>
<td valign="top" align="left">Antepartum hemorrhage</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.63 (0.35&#x2013;1.15)</td>
<td valign="top" align="center">3.86 (0.73&#x2013;20.25)</td>
<td valign="top" align="center">0.044</td>
</tr>
<tr>
<td valign="top" align="left">Postpartum hemorrhage</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.17 (1.10&#x2013;1.25)</td>
<td valign="top" align="center">1.04 (0.90&#x2013;1.21)</td>
<td valign="top" align="center">0.152</td>
</tr>
<tr>
<td valign="top" align="left">Cesarean section</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">2.92 (2.77&#x2013;3.08)</td>
<td valign="top" align="center">1.23 (0.93&#x2013;1.63)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5"><bold>Neonatal outcomes</bold></td>
</tr>
<tr>
<td valign="top" align="left">Fetal distress</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.69 (0.62&#x2013;0.76)</td>
<td valign="top" align="center">0.55 (0.39&#x2013;0.78)</td>
<td valign="top" align="center">0.219</td>
</tr>
<tr>
<td valign="top" align="left">Stillbirth or abnormal development</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">3.48 (3.01&#x2013;4.03)</td>
<td valign="top" align="center">0.82 (0.60&#x2013;1.14)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>All values are ORs (95% CIs). Values were determined by using logistic regression. Adjusted values were adjusted for maternal age, intrapartum BMI, parity and abnormal pregnancy history. The P-values were calculated for heterogeneity test.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap position="float" id="T7">
<label>TABLE 7</label>
<caption><p>Stratified analysis on the association of ART with maternal and offspring health by maternal age.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left"/>
<td valign="top" align="center"/>
<td valign="top" align="center" colspan="3">ART pregnancy<hr/></td>
</tr>
<tr>
<td valign="top" align="left">Maternal and offspring health</td>
<td valign="top" align="center">Naturally pregnancy</td>
<td valign="top" align="center">Maternal age &#x003C; 35 y</td>
<td valign="top" align="center">Maternal age &#x2265; 35 y</td>
<td valign="top" align="center"><italic>P</italic></td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="5"><bold>Pregnancy complications</bold></td>
</tr>
<tr>
<td valign="top" align="left">Gestational diabetes</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.59 (1.50 &#x2013; 1.68)</td>
<td valign="top" align="center">1.45 (1.31 &#x2013; 1.60)</td>
<td valign="top" align="center">0.116</td>
</tr>
<tr>
<td valign="top" align="left">Preeclampsia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.34 (1.19 &#x2013; 1.52)</td>
<td valign="top" align="center">1.19 (0.94 &#x2013; 1.50)</td>
<td valign="top" align="center">0.378</td>
</tr>
<tr>
<td valign="top" align="left">Severe preeclampsia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.15 (0.96 &#x2013; 1.37)</td>
<td valign="top" align="center">1.14 (0.82 &#x2013; 1.58)</td>
<td valign="top" align="center">0.963</td>
</tr>
<tr>
<td valign="top" align="left">Anemia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.02 (0.97 &#x2013; 1.08)</td>
<td valign="top" align="center">1.02 (0.91 &#x2013; 1.15)</td>
<td valign="top" align="center">1.000</td>
</tr>
<tr>
<td valign="top" align="left">Moderate or severe anemia</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.27 (1.13 &#x2013; 1.41)</td>
<td valign="top" align="center">1.24 (0.97 &#x2013; 1.58)</td>
<td valign="top" align="center">0.861</td>
</tr>
<tr>
<td valign="top" align="left">Liver-related diseases</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.15 (1.02 &#x2013; 1.29)</td>
<td valign="top" align="center">1.18 (0.95 &#x2013; 1.47)</td>
<td valign="top" align="center">0.839</td>
</tr>
<tr>
<td valign="top" align="left">Thyroid-related diseases</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.32 (1.23 &#x2013; 1.42)</td>
<td valign="top" align="center">1.39 (1.21 &#x2013; 1.60)</td>
<td valign="top" align="center">0.519</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5"><bold>Perinatal complications</bold></td>
</tr>
<tr>
<td valign="top" align="left">Preterm birth</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.56 (1.43 &#x2013; 1.70)</td>
<td valign="top" align="center">1.26 (1.06 &#x2013; 1.51)</td>
<td valign="top" align="center">0.034</td>
</tr>
<tr>
<td valign="top" align="left">Premature rupture of membrane</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.70 (0.65 &#x2013; 0.75)</td>
<td valign="top" align="center">0.67 (0.57 &#x2013; 0.80)</td>
<td valign="top" align="center">0.641</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5"><bold>Amniotic fluid pollution</bold></td>
</tr>
<tr>
<td valign="top" align="left">I&#x00B0;</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.81 (0.72 &#x2013; 0.91)</td>
<td valign="top" align="center">0.96 (0.74 &#x2013; 1.24)</td>
<td valign="top" align="center">0.240</td>
</tr>
<tr>
<td valign="top" align="left">II&#x00B0;</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.68 (0.60 &#x2013; 0.78)</td>
<td valign="top" align="center">0.71 (0.53 &#x2013; 0.94)</td>
<td valign="top" align="center">0.788</td>
</tr>
<tr>
<td valign="top" align="left">III&#x00B0;</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.62 (0.54 &#x2013; 0.70)</td>
<td valign="top" align="center">0.53 (0.38 &#x2013; 0.74)</td>
<td valign="top" align="center">0.390</td>
</tr>
<tr>
<td valign="top" align="left">Polyhydramnios</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.94 (0.82 &#x2013; 1.07)</td>
<td valign="top" align="center">1.40 (1.11 &#x2013; 1.77)</td>
<td valign="top" align="center">0.004</td>
</tr>
<tr>
<td valign="top" align="left">Oligohydramnios</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.03 (0.94 &#x2013; 1.13)</td>
<td valign="top" align="center">0.93 (0.76 &#x2013; 1.12)</td>
<td valign="top" align="center">0.351</td>
</tr>
<tr>
<td valign="top" align="left">Cord entanglement</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.91 (0.87 &#x2013; 0.96)</td>
<td valign="top" align="center">0.86 (0.78 &#x2013; 0.96)</td>
<td valign="top" align="center">0.335</td>
</tr>
<tr>
<td valign="top" align="left">Torsion of cord</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.98 (0.86 &#x2013; 1.11)</td>
<td valign="top" align="center">1.04 (0.78 &#x2013; 1.37)</td>
<td valign="top" align="center">0.706</td>
</tr>
<tr>
<td valign="top" align="left">Intrapartum fever</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.74 (0.68 &#x2013; 0.80)</td>
<td valign="top" align="center">0.78 (0.66 &#x2013; 0.93)</td>
<td valign="top" align="center">0.587</td>
</tr>
<tr>
<td valign="top" align="left">Placenta previa</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.77 (1.61 &#x2013; 1.94)</td>
<td valign="top" align="center">1.24 (1.06 &#x2013; 1.44)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left">Antepartum hemorrhage</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.89 (0.51 &#x2013; 1.56)</td>
<td valign="top" align="center">0.80 (0.29 &#x2013; 2.25)</td>
<td valign="top" align="center">0.858</td>
</tr>
<tr>
<td valign="top" align="left">Postpartum hemorrhage</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">1.27 (1.19 &#x2013; 1.35)</td>
<td valign="top" align="center">1.07 (0.94 &#x2013; 1.22)</td>
<td valign="top" align="center">0.020</td>
</tr>
<tr>
<td valign="top" align="left">Cesarean section</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">3.17 (3.00 &#x2013; 3.35)</td>
<td valign="top" align="center">2.39 (2.08 &#x2013; 2.76)</td>
<td valign="top" align="center">&#x003C;0.001</td>
</tr>
<tr>
<td valign="top" align="left" colspan="5"><bold>Neonatal outcomes</bold></td>
</tr>
<tr>
<td valign="top" align="left">Fetal distress</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">0.75 (0.68 &#x2013; 0.83)</td>
<td valign="top" align="center">0.58 (0.45 &#x2013; 0.75)</td>
<td valign="top" align="center">0.066</td>
</tr>
<tr>
<td valign="top" align="left">Stillbirth or abnormal development</td>
<td valign="top" align="center">1.0 (ref)</td>
<td valign="top" align="center">2.48 (2.13 &#x2013; 2.88)</td>
<td valign="top" align="center">2.25 (1.52 &#x2013; 3.32)</td>
<td valign="top" align="center">0.649</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p><italic>All values are ORs (95% CIs). Values were determined by using logistic regression. Adjusted values were adjusted for intrapartum BMI, parity, birth plurality and abnormal pregnancy history. The P-values were calculated for heterogeneity test.</italic></p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>This retrospective, hospital-based cohort study including 13,604 ART pregnancies and 198,002 naturally pregnancies was conducted in Nanjing, China from 2011 to 2020. The study showed the widespread application of ART in China, with the proportion of ART pregnancies increasing year by year in the past decade, and confirmed the increased risks of several adverse pregnancy outcomes in ART pregnancies. We found a 24.2-fold increase in the incidence of multiple births in ART pregnancies compared to naturally pregnancies, then stratified the analysis by birth plurality, suggesting multiple births are indeed an important factor leading to adverse pregnancy outcomes.</p>
<p>In the present study, the increased risks were found in ART pregnancy compared with naturally pregnancy: gestational diabetes (1.39-fold), preeclampsia (1.26-fold), moderate or severe anemia (1.20-fold), liver-related diseases (1.14-fold), thyroid-related diseases (1.29-fold), preterm birth (1.61-fold), placenta previa (1.48-fold), postpartum hemorrhage (1.14-fold), cesarean section (2.84-fold), and stillbirth or abnormal development (2.76-fold), which were largely consistent with the findings of previous studies (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B28">28</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>). Although these risks were reduced when restriction to singletons, significant differences remained. Some studies have suggested that infertility is one of the risk factors for adverse pregnancy outcomes (<xref ref-type="bibr" rid="B33">33</xref>). However, infertility factors cannot fully explain the associations. For infertile women, women conceived with ART had an increased risks of adverse pregnancy outcomes compared with women conceived with non-ART (<xref ref-type="bibr" rid="B34">34</xref>). Therefore, some researchers believe that the increased risks of adverse outcomes after ART conception are mainly related to ART manipulation factors (<xref ref-type="bibr" rid="B6">6</xref>), which is due to the addition of many non-physiological operations by ART. For example, the type of ovulation induction drugs used in the early stage, the composition of the culture medium, the storage time in the culture medium, the freezing and dissolution process of the embryo, polyspermic fertilization, and the hormone level at the time of implantation, all play an important role in the occurrence of adverse pregnancy outcomes (<xref ref-type="bibr" rid="B35">35</xref>). Other studies have pointed out that different methods of ART may lead to different types of adverse pregnancy outcomes (<xref ref-type="bibr" rid="B36">36</xref>). At the same time, the longer and more times of ART treatment, the greater the harm to women and their offspring (<xref ref-type="bibr" rid="B36">36</xref>). In addition, ART pregnancies may be more closely monitored than naturally pregnancies, which partly explains the higher incidence of adverse pregnancy outcomes in ART pregnancies (<xref ref-type="bibr" rid="B37">37</xref>). However, current studies and evidence cannot fully elucidate the mechanism by which ART increases the risk of adverse pregnancy outcomes, and the specific mechanism needs further research.</p>
<p>The main advantage of this study was the large sample size of pregnancy, which allowed us to conduct further subgroup analysis with enough power. And the data obtained from HIS database by using NLP technique is of high quality. However, there are some limitations in this study. First, the population we studied was limited to one city in eastern China (Nanjing). Therefore, we should be cautious in generalizing our findings to other regions. Second, we did not collect information on the ART form. The more intricate and invasive the ART form used, the more likely it was to cause adverse pregnancy outcomes. And the records of pre-pregnancy BMI, baseline endocrine level, causes of infertility, ovarian stimulation protocols, and quality of transferred embryos lacked in our database, were not included in this study. Third, the retrospective design of this study could not assess a causal relationship between ART and adverse pregnancy outcomes. These limitations should be considered in future studies.</p>
</sec>
<sec id="S5" sec-type="conclusion">
<title>Conclusion and Prospect</title>
<p>Women conceived by ART were at increased risks of several adverse pregnancy outcomes compared with women conceived naturally. Multiple pregnancies due to multiple embryos transferred could partly explain the increased risks. The transfer of single embryo of high quality should be promoted. However, ART singleton pregnancy still showed higher risks of several adverse pregnancy outcomes compared with naturally pregnancy, suggesting ART itself is also significantly correlated with pathological pregnancy. Therefore, policies related to ART indications should be strictly formulated to reverse the high rate of ART pregnancy. Given our findings, prenatal and intrapartum monitoring should be strengthened, and neonatal outcomes should be closely observed for ART pregnancy. And more research should be conducted to further clarify whether the increased risk of adverse pregnancy outcomes is due to ART itself, multiple births, or potential infertility.</p>
</sec>
<sec id="S6" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="S7">
<title>Ethics Statement</title>
<p>The studies involving human participants were reviewed and approved by the institutional review board of Women&#x2019;s Hospital of Nanjing Medical University (2020KY-011). Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="S8">
<title>Author Contributions</title>
<p>JW initiated, conceived, and supervised the study. WT and LH did data collection and performed the data analysis. All authors approved the final format of the submitted manuscript.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="pudiscl1" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="S9" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Jiangsu provincial key research and development program (BE2020626).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>L</given-names></name> <name><surname>Bu</surname> <given-names>Z</given-names></name> <name><surname>Huang</surname> <given-names>G</given-names></name> <name><surname>Sun</surname> <given-names>H</given-names></name> <name><surname>Deng</surname> <given-names>C</given-names></name> <name><surname>Sun</surname> <given-names>Y</given-names></name></person-group>. <article-title>Assisted reproductive technology in China: results generated from data reporting system by CSRM from 2013 to 2016.</article-title> <source><italic>Front Endocrinol (Lausanne).</italic></source> (<year>2020</year>) <volume>11</volume>:<issue>458</issue>. <pub-id pub-id-type="doi">10.3389/fendo.2020.00458</pub-id> <pub-id pub-id-type="pmid">33042000</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname> <given-names>F</given-names></name> <name><surname>Wang</surname> <given-names>DY</given-names></name> <name><surname>Fan</surname> <given-names>YJ</given-names></name> <name><surname>Qiu</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>L</given-names></name> <name><surname>Dai</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016.</article-title> <source><italic>Hum Reprod.</italic></source> (<year>2020</year>) <volume>35</volume>:<fpage>446</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dez245</pub-id> <pub-id pub-id-type="pmid">32020190</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>European IVF-Monitoring Consortium [EIM] for the European Society of Human Reproduction and Embryology [ESHRE], Calhaz-Jorge</surname> <given-names>C</given-names></name> <name><surname>de Geyter</surname> <given-names>C</given-names></name> <name><surname>Kupka</surname> <given-names>MS</given-names></name> <name><surname>de Mouzon</surname> <given-names>J</given-names></name> <name><surname>Erb</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE.</article-title> <source><italic>Hum Reprod.</italic></source> (<year>2016</year>) <volume>31</volume>:<fpage>1638</fpage>&#x2013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dew151</pub-id> <pub-id pub-id-type="pmid">27496943</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farhi</surname> <given-names>A</given-names></name> <name><surname>Reichman</surname> <given-names>B</given-names></name> <name><surname>Boyko</surname> <given-names>V</given-names></name> <name><surname>Hourvitz</surname> <given-names>A</given-names></name> <name><surname>Ron-El</surname> <given-names>R</given-names></name> <name><surname>Lerner-Geva</surname> <given-names>L</given-names></name></person-group>. <article-title>Maternal and neonatal health outcomes following assisted reproduction.</article-title> <source><italic>Reprod Biomed Online.</italic></source> (<year>2013</year>) <volume>26</volume>:<fpage>454</fpage>&#x2013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2013.01.014</pub-id> <pub-id pub-id-type="pmid">23518031</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malchau</surname> <given-names>SS</given-names></name> <name><surname>Loft</surname> <given-names>A</given-names></name> <name><surname>Larsen</surname> <given-names>EC</given-names></name> <name><surname>Aaris Henningsen</surname> <given-names>AK</given-names></name> <name><surname>Rasmussen</surname> <given-names>S</given-names></name> <name><surname>Andersen</surname> <given-names>AN</given-names></name><etal/></person-group> <article-title>Perinatal outcomes in 375 children born after oocyte donation: a Danish national cohort study.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2013</year>) <volume>99</volume>:<fpage>1637</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2013.01.128</pub-id> <pub-id pub-id-type="pmid">23465822</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>M</given-names></name> <name><surname>Kurinczuk</surname> <given-names>JJ</given-names></name> <name><surname>de Klerk</surname> <given-names>N</given-names></name> <name><surname>Burton</surname> <given-names>P</given-names></name> <name><surname>Bower</surname> <given-names>C</given-names></name></person-group>. <article-title>Assisted reproductive technology and major birth defects in Western Australia.</article-title> <source><italic>Obstet Gynecol.</italic></source> (<year>2012</year>) <volume>120</volume>:<fpage>852</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0b013e318269c282</pub-id> <pub-id pub-id-type="pmid">22996103</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujii</surname> <given-names>M</given-names></name> <name><surname>Matsuoka</surname> <given-names>R</given-names></name> <name><surname>Bergel</surname> <given-names>E</given-names></name> <name><surname>van der Poel</surname> <given-names>S</given-names></name> <name><surname>Okai</surname> <given-names>T</given-names></name></person-group>. <article-title>Perinatal risk in singleton pregnancies after in vitro fertilization.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2010</year>) <volume>94</volume>:<fpage>2113</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.12.031</pub-id> <pub-id pub-id-type="pmid">20117775</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rozdarz</surname> <given-names>KM</given-names></name> <name><surname>Flatley</surname> <given-names>CJ</given-names></name> <name><surname>Kumar</surname> <given-names>S</given-names></name></person-group>. <article-title>Intrapartum and neonatal outcomes in singleton pregnancies following conception by assisted reproduction techniques.</article-title> <source><italic>Aust N Z J Obstet Gynaecol.</italic></source> (<year>2017</year>) <volume>57</volume>:<fpage>588</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1111/ajo.12620</pub-id> <pub-id pub-id-type="pmid">28374410</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Farquhar</surname> <given-names>C</given-names></name> <name><surname>Rishworth</surname> <given-names>JR</given-names></name> <name><surname>Brown</surname> <given-names>J</given-names></name> <name><surname>Nelen</surname> <given-names>WL</given-names></name> <name><surname>Marjoribanks</surname> <given-names>J</given-names></name></person-group>. <article-title>Assisted reproductive technology: an overview of Cochrane Reviews.</article-title> <source><italic>Cochrane Database Syst Rev.</italic></source> (<year>2015</year>) <volume>7</volume>:<issue>CD010537</issue>. <pub-id pub-id-type="doi">10.1002/14651858.CD010537.pub4</pub-id> <pub-id pub-id-type="pmid">26174592</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Sheng</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>H</given-names></name> <name><surname>Gao</surname> <given-names>S</given-names></name></person-group>. <article-title>Assisted reproductive technology and the risk of pregnancy-related complications and adverse pregnancy outcomes in singleton pregnancies: a meta-analysis of cohort studies.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2016</year>) <volume>105</volume>:<fpage>73</fpage>&#x2013;<lpage>85.e71&#x2013;76</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2015.09.007</pub-id> <pub-id pub-id-type="pmid">26453266</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname> <given-names>S</given-names></name> <name><surname>Hong</surname> <given-names>C</given-names></name> <name><surname>Wang</surname> <given-names>ET</given-names></name> <name><surname>Alexander</surname> <given-names>C</given-names></name> <name><surname>Gregory</surname> <given-names>KD</given-names></name> <name><surname>Pisarska</surname> <given-names>MD</given-names></name></person-group>. <article-title>Pregnancy outcomes in very advanced maternal age pregnancies: the impact of assisted reproductive technology.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2015</year>) <volume>103</volume>:<fpage>76</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2014.09.037</pub-id> <pub-id pub-id-type="pmid">25450294</pub-id></citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geisler</surname> <given-names>ME</given-names></name> <name><surname>O&#x2019;Mahony</surname> <given-names>A</given-names></name> <name><surname>Meaney</surname> <given-names>S</given-names></name> <name><surname>Waterstone</surname> <given-names>JJ</given-names></name> <name><surname>O&#x2019;Donoghue</surname> <given-names>K</given-names></name></person-group>. <article-title>Obstetric and perinatal outcomes of twin pregnancies conceived following IVF/ICSI treatment compared with spontaneously conceived twin pregnancies.</article-title> <source><italic>Eur J Obstet Gynecol Reprod Biol.</italic></source> (<year>2014</year>) <volume>181</volume>:<fpage>78</fpage>&#x2013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejogrb.2014.07.033</pub-id> <pub-id pub-id-type="pmid">25129152</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>YA</given-names></name> <name><surname>Ledger</surname> <given-names>W</given-names></name> <name><surname>Sullivan</surname> <given-names>EA</given-names></name></person-group>. <article-title>Birthweight percentiles by gestational age for births following assisted reproductive technology in Australia and New Zealand, 2002-2010.</article-title> <source><italic>Hum Reprod.</italic></source> (<year>2014</year>) <volume>29</volume>:<fpage>1787</fpage>&#x2013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deu120</pub-id> <pub-id pub-id-type="pmid">24908671</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname> <given-names>N</given-names></name> <name><surname>Sierra</surname> <given-names>S</given-names></name> <name><surname>Genetics</surname> <given-names>C</given-names></name> <name><surname>Special</surname> <given-names>C</given-names></name></person-group>. <article-title>Pregnancy outcomes after assisted human reproduction.</article-title> <source><italic>J Obstet Gynaecol Can.</italic></source> (<year>2014</year>) <volume>36</volume>:<fpage>64</fpage>&#x2013;<lpage>83</lpage>.</citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>J</given-names></name> <name><surname>Jiang</surname> <given-names>J</given-names></name> <name><surname>Ding</surname> <given-names>C</given-names></name> <name><surname>Dai</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Xia</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Birth defects in children conceived by in vitro fertilization and intracytoplasmic sperm injection: a meta-analysis.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2012</year>) <volume>97</volume>:<fpage>1331</fpage>&#x2013;<lpage>7.e1&#x2013;e4</lpage>.</citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schieve</surname> <given-names>LA</given-names></name> <name><surname>Meikle</surname> <given-names>SF</given-names></name> <name><surname>Ferre</surname> <given-names>C</given-names></name> <name><surname>Peterson</surname> <given-names>HB</given-names></name> <name><surname>Jeng</surname> <given-names>G</given-names></name> <name><surname>Wilcox</surname> <given-names>LS</given-names></name></person-group>. <article-title>Low and very low birth weight in infants conceived with use of assisted reproductive technology.</article-title> <source><italic>N Engl J Med.</italic></source> (<year>2002</year>) <volume>346</volume>:<fpage>731</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1056/nejmoa010806</pub-id> <pub-id pub-id-type="pmid">11882728</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seggers</surname> <given-names>J</given-names></name> <name><surname>Pontesilli</surname> <given-names>M</given-names></name> <name><surname>Ravelli</surname> <given-names>ACJ</given-names></name> <name><surname>Painter</surname> <given-names>RC</given-names></name> <name><surname>Hadders-Algra</surname> <given-names>M</given-names></name> <name><surname>Heineman</surname> <given-names>MJ</given-names></name><etal/></person-group> <article-title>Effects of in vitro fertilization and maternal characteristics on perinatal outcomes: a population-based study using siblings.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2016</year>) <volume>105</volume>:<fpage>590</fpage>&#x2013;<lpage>8.e592</lpage>.</citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Neubourg</surname> <given-names>D</given-names></name> <name><surname>Gerris</surname> <given-names>J</given-names></name> <name><surname>Mangelschots</surname> <given-names>K</given-names></name> <name><surname>Van Royen</surname> <given-names>E</given-names></name> <name><surname>Vercruyssen</surname> <given-names>M</given-names></name> <name><surname>Steylemans</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>The obstetrical and neonatal outcome of babies born after single-embryo transfer in IVF/ICSI compares favourably to spontaneously conceived babies.</article-title> <source><italic>Hum Reprod.</italic></source> (<year>2006</year>) <volume>21</volume>:<fpage>1041</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dei424</pub-id> <pub-id pub-id-type="pmid">16428333</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Geyter</surname> <given-names>C</given-names></name> <name><surname>De Geyter</surname> <given-names>M</given-names></name> <name><surname>Steimann</surname> <given-names>S</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Holzgreve</surname> <given-names>W</given-names></name></person-group>. <article-title>Comparative birth weights of singletons born after assisted reproduction and natural conception in previously infertile women.</article-title> <source><italic>Hum Reprod.</italic></source> (<year>2006</year>) <volume>21</volume>:<fpage>705</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dei378</pub-id> <pub-id pub-id-type="pmid">16284064</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kozinszky</surname> <given-names>Z</given-names></name> <name><surname>Zadori</surname> <given-names>J</given-names></name> <name><surname>Orvos</surname> <given-names>H</given-names></name> <name><surname>Katona</surname> <given-names>M</given-names></name> <name><surname>Pal</surname> <given-names>A</given-names></name> <name><surname>Kovacs</surname> <given-names>L</given-names></name></person-group>. <article-title>Obstetric and neonatal risk of pregnancies after assisted reproductive technology: a matched control study.</article-title> <source><italic>Acta Obstet Gynecol Scand.</italic></source> (<year>2003</year>) <volume>82</volume>:<fpage>850</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1034/j.1600-0412.2003.00225.x</pub-id> <pub-id pub-id-type="pmid">12911448</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname> <given-names>I</given-names></name> <name><surname>Hindoyan</surname> <given-names>R</given-names></name> <name><surname>Landay</surname> <given-names>M</given-names></name> <name><surname>Ho</surname> <given-names>J</given-names></name> <name><surname>Ingles</surname> <given-names>SA</given-names></name> <name><surname>McGinnis</surname> <given-names>LK</given-names></name><etal/></person-group> <article-title>Perinatal outcomes after natural conception versus in vitro fertilization (IVF) in gestational surrogates: a model to evaluate IVF treatment versus maternal effects.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2017</year>) <volume>108</volume>:<fpage>993</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2017.09.014</pub-id> <pub-id pub-id-type="pmid">29202976</pub-id></citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname> <given-names>Z</given-names></name> <name><surname>Chen</surname> <given-names>ZJ</given-names></name> <name><surname>Huang</surname> <given-names>G</given-names></name> <name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Wu</surname> <given-names>Q</given-names></name> <name><surname>Ma</surname> <given-names>Y</given-names></name><etal/></person-group> <article-title>Live birth sex ratio after in vitro fertilization and embryo transfer in China&#x2013;an analysis of 121,247 babies from 18 centers.</article-title> <source><italic>PLoS One.</italic></source> (<year>2014</year>) <volume>9</volume>:<issue>e113522</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0113522</pub-id> <pub-id pub-id-type="pmid">25412419</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moini</surname> <given-names>A</given-names></name> <name><surname>Shiva</surname> <given-names>M</given-names></name> <name><surname>Arabipoor</surname> <given-names>A</given-names></name> <name><surname>Hosseini</surname> <given-names>R</given-names></name> <name><surname>Chehrazi</surname> <given-names>M</given-names></name> <name><surname>Sadeghi</surname> <given-names>M</given-names></name></person-group>. <article-title>Obstetric and neonatal outcomes of twin pregnancies conceived by assisted reproductive technology compared with twin pregnancies conceived spontaneously: a prospective follow-up study.</article-title> <source><italic>Eur J Obstet Gynecol Reprod Biol.</italic></source> (<year>2012</year>) <volume>165</volume>:<fpage>29</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejogrb.2012.07.008</pub-id> <pub-id pub-id-type="pmid">22884795</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brekke</surname> <given-names>PH</given-names></name> <name><surname>Rama</surname> <given-names>T</given-names></name> <name><surname>Pilan</surname> <given-names>I</given-names></name> <name><surname>Nytro</surname> <given-names>O</given-names></name> <name><surname>Ovrelid</surname> <given-names>L</given-names></name></person-group>. <article-title>Synthetic data for annotation and extraction of family history information from clinical text.</article-title> <source><italic>J Biomed Semantics.</italic></source> (<year>2021</year>) <volume>12</volume>:<issue>11</issue>. <pub-id pub-id-type="doi">10.1186/s13326-021-00244-2</pub-id> <pub-id pub-id-type="pmid">34261535</pub-id></citation></ref>
<ref id="B25"><label>25.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Son</surname> <given-names>M</given-names></name> <name><surname>Gallagher</surname> <given-names>K</given-names></name> <name><surname>Lo</surname> <given-names>JY</given-names></name> <name><surname>Lindgren</surname> <given-names>E</given-names></name> <name><surname>Burris</surname> <given-names>HH</given-names></name> <name><surname>Dysart</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Coronavirus Disease 2019 (COVID-19) pandemic and pregnancy outcomes in a U.S. Population.</article-title> <source><italic>Obstet Gynecol.</italic></source> (<year>2021</year>) <volume>138</volume>:<fpage>542</fpage>&#x2013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1097/AOG.0000000000004547</pub-id> <pub-id pub-id-type="pmid">34433180</pub-id></citation></ref>
<ref id="B26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flythe</surname> <given-names>JE</given-names></name> <name><surname>Assimon</surname> <given-names>MM</given-names></name> <name><surname>Tugman</surname> <given-names>MJ</given-names></name> <name><surname>Chang</surname> <given-names>EH</given-names></name> <name><surname>Gupta</surname> <given-names>S</given-names></name> <name><surname>Shah</surname> <given-names>J</given-names></name><etal/></person-group> <article-title>Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States.</article-title> <source><italic>Am J Kidney Dis.</italic></source> (<year>2021</year>) <volume>77</volume>:<issue>190-203.e191</issue>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2020.09.003</pub-id> <pub-id pub-id-type="pmid">32961244</pub-id></citation></ref>
<ref id="B27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stephenson</surname> <given-names>AL</given-names></name> <name><surname>Sykes</surname> <given-names>J</given-names></name> <name><surname>Stanojevic</surname> <given-names>S</given-names></name> <name><surname>Quon</surname> <given-names>BS</given-names></name> <name><surname>Marshall</surname> <given-names>BC</given-names></name> <name><surname>Petren</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study.</article-title> <source><italic>Ann Intern Med.</italic></source> (<year>2017</year>) <volume>166</volume>:<fpage>537</fpage>&#x2013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.7326/M16-0858</pub-id> <pub-id pub-id-type="pmid">28288488</pub-id></citation></ref>
<ref id="B28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nagata</surname> <given-names>C</given-names></name> <name><surname>Yang</surname> <given-names>L</given-names></name> <name><surname>Yamamoto-Hanada</surname> <given-names>K</given-names></name> <name><surname>Mezawa</surname> <given-names>H</given-names></name> <name><surname>Ayabe</surname> <given-names>T</given-names></name> <name><surname>Ishizuka</surname> <given-names>K</given-names></name><etal/></person-group> <article-title>Complications and adverse outcomes in pregnancy and childbirth among women who conceived by assisted reproductive technologies: a nationwide birth cohort study of Japan environment and children&#x2019;s study.</article-title> <source><italic>BMC Pregnancy Childbirth.</italic></source> (<year>2019</year>) <volume>19</volume>:<issue>77</issue>. <pub-id pub-id-type="doi">10.1186/s12884-019-2213-y</pub-id> <pub-id pub-id-type="pmid">30786865</pub-id></citation></ref>
<ref id="B29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vermey</surname> <given-names>BG</given-names></name> <name><surname>Buchanan</surname> <given-names>A</given-names></name> <name><surname>Chambers</surname> <given-names>GM</given-names></name> <name><surname>Kolibianakis</surname> <given-names>EM</given-names></name> <name><surname>Bosdou</surname> <given-names>J</given-names></name> <name><surname>Chapman</surname> <given-names>MG</given-names></name><etal/></person-group> <article-title>Are singleton pregnancies after assisted reproduction technology (ART) associated with a higher risk of placental anomalies compared with non-ART singleton pregnancies? A systematic review and meta-analysis.</article-title> <source><italic>BJOG.</italic></source> (<year>2019</year>) <volume>126</volume>:<fpage>209</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1111/1471-0528.15227</pub-id> <pub-id pub-id-type="pmid">29740927</pub-id></citation></ref>
<ref id="B30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>H</given-names></name> <name><surname>Sheng</surname> <given-names>X</given-names></name> <name><surname>Liang</surname> <given-names>D</given-names></name> <name><surname>Tan</surname> <given-names>H</given-names></name> <name><surname>Xia</surname> <given-names>J</given-names></name></person-group>. <article-title>Pregnancy-related complications and adverse pregnancy outcomes in multiple pregnancies resulting from assisted reproductive technology: a meta-analysis of cohort studies.</article-title> <source><italic>Fertil Steril.</italic></source> (<year>2015</year>) <volume>103</volume>:<fpage>1492</fpage>&#x2013;<lpage>508.e1491&#x2013;7</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2015.03.018</pub-id> <pub-id pub-id-type="pmid">25910567</pub-id></citation></ref>
<ref id="B31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname> <given-names>S</given-names></name> <name><surname>Shetty</surname> <given-names>A</given-names></name> <name><surname>Hamilton</surname> <given-names>M</given-names></name> <name><surname>Bhattacharya</surname> <given-names>S</given-names></name> <name><surname>Maheshwari</surname> <given-names>A</given-names></name></person-group>. <article-title>Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2012</year>) <volume>18</volume>:<fpage>485</fpage>&#x2013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dms018</pub-id> <pub-id pub-id-type="pmid">22611174</pub-id></citation></ref>
<ref id="B32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Esh-Broder</surname> <given-names>E</given-names></name> <name><surname>Ariel</surname> <given-names>I</given-names></name> <name><surname>Abas-Bashir</surname> <given-names>N</given-names></name> <name><surname>Bdolah</surname> <given-names>Y</given-names></name> <name><surname>Celnikier</surname> <given-names>DH</given-names></name></person-group>. <article-title>Placenta accreta is associated with IVF pregnancies: a retrospective chart review.</article-title> <source><italic>BJOG.</italic></source> (<year>2011</year>) <volume>118</volume>:<fpage>1084</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-0528.2011.02976.x</pub-id> <pub-id pub-id-type="pmid">21585640</pub-id></citation></ref>
<ref id="B33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname> <given-names>LL</given-names></name> <name><surname>Lan</surname> <given-names>YL</given-names></name> <name><surname>Wang</surname> <given-names>SY</given-names></name> <name><surname>Feng</surname> <given-names>W</given-names></name> <name><surname>Zhai</surname> <given-names>ZJ</given-names></name></person-group>. <article-title>Perinatal complications and live-birth outcomes following assisted reproductive technology: a retrospective cohort study.</article-title> <source><italic>Chin Med J (Engl).</italic></source> (<year>2019</year>) <volume>132</volume>:<fpage>2408</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1097/CM9.0000000000000484</pub-id> <pub-id pub-id-type="pmid">31634242</pub-id></citation></ref>
<ref id="B34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pinborg</surname> <given-names>A</given-names></name> <name><surname>Wennerholm</surname> <given-names>UB</given-names></name> <name><surname>Romundstad</surname> <given-names>LB</given-names></name> <name><surname>Loft</surname> <given-names>A</given-names></name> <name><surname>Aittomaki</surname> <given-names>K</given-names></name> <name><surname>Soderstrom-Anttila</surname> <given-names>V</given-names></name><etal/></person-group> <article-title>Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis.</article-title> <source><italic>Hum Reprod Update.</italic></source> (<year>2013</year>) <volume>19</volume>:<fpage>87</fpage>&#x2013;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dms044</pub-id> <pub-id pub-id-type="pmid">23154145</pub-id></citation></ref>
<ref id="B35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palomba</surname> <given-names>S</given-names></name> <name><surname>Homburg</surname> <given-names>R</given-names></name> <name><surname>Santagni</surname> <given-names>S</given-names></name> <name><surname>La Sala</surname> <given-names>GB</given-names></name> <name><surname>Orvieto</surname> <given-names>R</given-names></name></person-group>. <article-title>Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review.</article-title> <source><italic>Reprod Biol Endocrinol.</italic></source> (<year>2016</year>) <volume>14</volume>:<issue>76</issue>. <pub-id pub-id-type="doi">10.1186/s12958-016-0211-8</pub-id> <pub-id pub-id-type="pmid">27814762</pub-id></citation></ref>
<ref id="B36"><label>36.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marino</surname> <given-names>JL</given-names></name> <name><surname>Moore</surname> <given-names>VM</given-names></name> <name><surname>Willson</surname> <given-names>KJ</given-names></name> <name><surname>Rumbold</surname> <given-names>A</given-names></name> <name><surname>Whitrow</surname> <given-names>MJ</given-names></name> <name><surname>Giles</surname> <given-names>LC</given-names></name><etal/></person-group> <article-title>Perinatal outcomes by mode of assisted conception and sub-fertility in an Australian data linkage cohort.</article-title> <source><italic>PLoS One.</italic></source> (<year>2014</year>) <volume>9</volume>:<issue>e80398</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0080398</pub-id> <pub-id pub-id-type="pmid">24416127</pub-id></citation></ref>
<ref id="B37"><label>37.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname> <given-names>M</given-names></name> <name><surname>Kurinczuk</surname> <given-names>JJ</given-names></name> <name><surname>Bower</surname> <given-names>C</given-names></name> <name><surname>Webb</surname> <given-names>S</given-names></name></person-group>. <article-title>The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization.</article-title> <source><italic>N Engl J Med.</italic></source> (<year>2002</year>) <volume>346</volume>:<fpage>725</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1056/nejmoa010035</pub-id> <pub-id pub-id-type="pmid">11882727</pub-id></citation></ref>
</ref-list>
<glossary>
<title>Abbreviations</title>
<def-list id="DL1">
<def-item><term>ART</term><def><p>assisted reproductive technology</p></def></def-item>
<def-item><term>ICSI</term><def><p>intracytoplasmic sperm injection</p></def></def-item>
<def-item><term>IVF</term><def><p><italic>in vitro</italic> fertilization</p></def></def-item>
<def-item><term>OI</term><def><p>ovulation induction</p></def></def-item>
<def-item><term>GIFT</term><def><p>gamete intra-fallopian transfer</p></def></def-item>
<def-item><term>AI</term><def><p>artificial insemination</p></def></def-item>
<def-item><term>HIS</term><def><p>hospital information system</p></def></def-item>
<def-item><term>NLP</term><def><p>natural language processing</p></def></def-item>
<def-item><term>BMI</term><def><p>body mass index</p></def></def-item>
<def-item><term>OR</term><def><p>odds ratio</p></def></def-item>
<def-item><term>CI</term><def><p>confidence intervals.</p></def></def-item>
</def-list>
</glossary>
</back>
</article>